Abstract Details

Title Rituximab Therapy in a Patient with Recurrent Hashimoto's Encephalitis (HE), and Progressive Encephalomyelitis with Rigidity and Myoclonus (PERM)

Topic Neurotoxicology

Presentation(s) (-)

Poster/Presentation
Number 164

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Darine Kassar, MD	Dr. Kassar has nothing to disclose.
Srikanth Damodaram, MD	No disclosure on file
Stanley J. Iyadurai, MD, PhD, FAAN (Johns Hopkins All Children's Hospital/Catalyst)	Dr. Iyadurai has received personal compensation for serving as an employee of Catalyst Pharmaceuticals. Dr. Iyadurai has received stock or an ownership interest from Catalyst Pharmaceuticals.
Pratap R. Chand, MD, FRCP, FAAN (St Louis University School of Medicine)	Dr. Chand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. An immediate family member of Dr. Chand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acorda. Dr. Chand has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Neuroscience.
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��